Literature DB >> 10696063

Oxygen-independent upregulation of vascular endothelial growth factor and vascular barrier dysfunction during ventilated pulmonary ischemia in isolated ferret lungs.

P M Becker1, A Alcasabas, A Y Yu, G L Semenza, T E Bunton.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent mediator of endothelial barrier dysfunction, and is upregulated during ischemia in many organs. Because ventilated pulmonary ischemia causes a marked increase in pulmonary vascular permeability, we hypothesized that VEGF would increase during ischemic lung injury. To test this hypothesis, we measured VEGF expression by Northern and Western blot analysis in isolated ferret lungs after 45 (n = 12) or 180 (n = 12) min of ventilated (95% or 0% O(2)) ischemia. Pulmonary vascular permeability, assessed by measurement of osmotic reflection coefficient for albumin (sigma(alb)), was evaluated in the same lungs, as was expression of the transcription factor, hypoxia-inducible factor (HIF)-1alpha. Distribution of VEGF as a function of ischemic time and oxygen tension was also evaluated by immunohistochemical staining in separate groups of lungs (n = 3). VEGF messenger RNA (mRNA) increased 3-fold by 180 min of ventilated ischemia, independent of oxygen tension. VEGF protein increased in parallel to mRNA. Immunohistochemical staining demonstrated the appearance of VEGF protein along alveolar septae after 180 min of hyperoxic ischemia, and after 45 or 180 min of hypoxic ischemia. sigma(alb) was not altered by 45 min of hyperoxic ischemia (0.69+/-0.09 versus 0.50+/-0.12, respectively), but decreased significantly after 180 min of hyperoxic ischemia and after 45 and 180 min of hypoxic ischemia (0.20+/-0.03, 0.26+/-0.08, and 0.23+/-0.03, respectively; P<0.05). HIF-1alpha mRNA increased during both hyperoxic and hypoxic ischemia, but HIF-1alpha protein increased only during hypoxic ischemia. These results implicate VEGF as a potential mediator of increased pulmonary vascular permeability in this model of acute lung injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10696063     DOI: 10.1165/ajrcmb.22.3.3814

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  21 in total

1.  Interleukin-6 mediates pulmonary vascular permeability in a two-hit model of ventilator-associated lung injury.

Authors:  Ozlem U Gurkan; Chaoxia He; Rachel Zielinski; Hamid Rabb; Landon S King; Jeffrey M Dodd-o; Franco R D'Alessio; Neil Aggarwal; David Pearse; Patrice M Becker
Journal:  Exp Lung Res       Date:  2011-11-01       Impact factor: 2.459

2.  Dopamine inhibits pulmonary edema through the VEGF-VEGFR2 axis in a murine model of acute lung injury.

Authors:  Pawan K Vohra; Luke H Hoeppner; Gunisha Sagar; Shamit K Dutta; Sanjay Misra; Rolf D Hubmayr; Debabrata Mukhopadhyay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

Review 3.  HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease.

Authors:  Larissa A Shimoda; Gregg L Semenza
Journal:  Am J Respir Crit Care Med       Date:  2011-01-15       Impact factor: 21.405

Review 4.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

5.  Redox Role of ROS and Inflammation in Pulmonary Diseases.

Authors:  Li Zuo; Denethi Wijegunawardana
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Angiogenesis in chronic lung disease.

Authors:  Norbert F Voelkel; Ivor S Douglas; Mark Nicolls
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

Review 7.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

Review 8.  Vascular endothelial growth factors in pulmonary edema: an update.

Authors:  Ioanna Kosmidou; Dimitrios Karmpaliotis; Ajay J Kirtane; Hal V Barron; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2007-06-07       Impact factor: 2.300

9.  Post-transcriptional regulation of VEGF-A mRNA levels by mitogen-activated protein kinases (MAPKs) during metabolic stress associated with ischaemia/reperfusion.

Authors:  Bryan W Miller; Joanna M Hay; Sally A Prigent; Martin Dickens
Journal:  Mol Cell Biochem       Date:  2012-05-05       Impact factor: 3.396

10.  Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edema.

Authors:  Masaki Watanabe; Julie L Boyer; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2009-06       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.